Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

PHYSICAL BIOLOGY is a prominent journal published by IOP Publishing Ltd, focusing on the interdisciplinary field of biophysics, cell biology, molecular biology, and structural biology. Established in 2004, this journal has quickly made its mark in the academic community, currently ranking in the Q2 category in Biophysics and Q3 in Cell, Molecular, and Structural Biology as of 2023. With an ISSN of 1478-3967 and E-ISSN 1478-3975, it serves as a vital platform for disseminating groundbreaking research that bridges physical principles with biological systems. While currently not providing Open Access options, the journal offers access to a wealth of knowledge crucial for researchers, professionals, and students alike who are eager to explore the intricacies of living organisms through a physical lens. Situated in the United Kingdom, PHYSICAL BIOLOGY emphasizes the importance of multiscale approaches and innovative techniques, making it an essential resource for those working at the intersection of physics and biology.

BIOCHEMISTRY-MOSCOW is a distinguished academic journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on pivotal research in the fields of biochemistry, biophysics, geriatrics, and broader medical sciences. Established in 1972, the journal has a rich history of disseminating critical findings and innovative studies, making significant contributions to the advancement of biochemical knowledge and applications. With its Q2 ranking in various categories including biochemistry and gerontology, the journal commands respect within the scientific community, offering a reputable platform for both established researchers and emerging scholars alike. Although traditionally not an open-access journal, it provides a wealth of information accessible through institutional subscriptions, ensuring the latest advancements reach a global audience. The journal aims to enhance understanding of biochemical processes and their implications for human health, and its commitment to high-quality peer-reviewed content has established it as a vital resource for those invested in the life sciences.

TRAFFIC is a distinguished academic journal published by Wiley, serving as a vital resource in the fields of Biochemistry, Cell Biology, Genetics, Molecular Biology, and Structural Biology. With an impressive growth trajectory since its inception in 2000, the journal has consistently maintained a Q1 category ranking in the latest 2023 evaluations, placing it amongst the top-tier publications in its fields. TRAFFIC is based in Denmark and has become a cornerstone for researchers and professionals seeking to explore the intricate dynamics of cellular transport and its implications across biological processes. Despite not being an open-access journal, TRAFFIC offers comprehensive access options, ensuring vital contributions to the scientific community are readily available. With a proven track record and substantial impact, as evidenced by its Scopus rankings—such as rank #11 in Structural Biology—TRAFFIC continues to be an essential platform for disseminating influential research and fostering academic discourse.

The JOURNAL OF BIOLOGICAL PHYSICS, published by Springer, is a premier interdisciplinary journal that focuses on the intersection of biological sciences and physics. With an ISSN of 0092-0606 and an E-ISSN of 1573-0689, this journal serves as a significant platform for researchers and professionals to publish innovative studies, covering fields such as atomic and molecular physics, biophysics, cell biology, and molecular biology. The journal has been a key player since its inception in 1973, showcasing rigorous scientific inquiry and advancing knowledge within these domains, reflected in its categorization in the Q3 and Q4 quartiles of various relevant fields as of 2023. While it currently operates without an Open Access model, the journal continues to provide pivotal contributions to its audience, supporting academic and practical advancements in biological physics while engaging a broad scope of scholarly discourse.

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

Biophysical Reports is an esteemed peer-reviewed journal published by Elsevier, dedicated to advancing the field of biophysics and related disciplines. Since its inception in 2021, this journal has rapidly gained recognition, achieving a Q1 ranking in Biophysics and Q2 rankings in both Biochemistry categories and Biotechnology as of 2023. The journal serves as a pivotal platform for disseminating innovative research findings and theoretical advancements, catering to a diverse readership that includes researchers, professionals, and students in the life sciences. With an ISSN of 2667-0747, Biophysical Reports aims to bridge the gap between molecular biochemistry and physical sciences, providing critical insights that contribute to the understanding of biomolecular processes. While offering no open-access options, it adheres to rigorous publication standards, ensuring high-quality content that reflects contemporary challenges and breakthroughs in biophysical research. For those engaged in the biosciences, this journal stands as an invaluable resource for exploring the intricacies of molecular interactions and the implications for biotechnology and genetic studies.

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, published by the Chinese Academy of Sciences, Institute of Biophysics, serves as a vital platform for advancing the field of biochemistry and biophysics. With a legacy dating from 1996 through 2024, this journal has been instrumental in disseminating critical research findings and innovative methodologies that push the boundaries of our understanding of biochemical processes and biophysical phenomena. Though currently unlisted as Open Access, the journal embodies rigorous peer-reviewed scholarship, positioned in the competitive Q4 quartile for both biochemistry and biophysics categories as per the 2023 metrics. It caters to a diverse audience, including researchers, professionals, and students who are keen to explore foundational and emerging concepts within these dynamic fields. By publishing comprehensive studies and reviews, the journal not only highlights progress but also fosters collaboration and dialogue among scholars worldwide, making it an essential resource for anyone invested in biochemical and biophysical research.

Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.